Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Gomes, Luis Eduardo Mianida Silva, Francesca Aparecida RamosPascoal, Lívia BitencourtRicci, Renato LazarinNogueira, GuilhermeCamargo, Michel Garderede Lourdes Setsuko Ayrizono, MariaFagundes, João JoséLeal, Raquel Franco2024-05-172024-05-1720191807-5932S1807-59322019000100405-scl10.6061/clinics/2019/e1517https://repositorio-aptaregional.agricultura.sp.gov.br/handle/123456789/2016Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?Artigos